| Karla Daniela Calzada Morales, MD | |
|
736 Cambridge St, Brighton, MA 02135-2907 | |
| (617) 789-3000 | |
| Not Available |
| Full Name | Karla Daniela Calzada Morales |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 12 Years |
| Location | 736 Cambridge St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013368349 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 282865 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northside Behavioral Health Center, Inc | 9931187911 | 12 |
News Archive
YM BioSciences Inc., announces that it filed a Form 6K describing that certain US patents for nimotuzumab licensed to YM's majority-owned Canadian subsidiary , CIMYM BioSciences Inc., have become subject to a lien in the United States, pursuant to a court order, to a third party.
An emergency physician-led workgroup has published five primary and seven secondary recommendations about how to maximize the value of health information exchange (HIE) in emergency departments. The recommendations were published online Tuesday in Annals of Emergency Medicine ("Health Information Exchange in Emergency Medicine").
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Biometric systems are no longer reserved for Government users. Enterprise markets such as Banking and Corporations are increasingly seeing the benefits offered by biometric solutions. To accommodate these new opportunities, Precise Biometrics launches a new generation of competitive fingerprint readers which are designed to meet a range of specific but different customer demands.
More and more people are surviving their cancer. Unfortunately, sometimes survival can come with pain. Although many people won't feel any pain after their cancer treatment, some may have chronic, bothersome pain.
› Verified 6 days ago
| Entity Name | Northside Behavioral Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669498002 PECOS PAC ID: 9931187911 Enrollment ID: O20040708000284 |
News Archive
YM BioSciences Inc., announces that it filed a Form 6K describing that certain US patents for nimotuzumab licensed to YM's majority-owned Canadian subsidiary , CIMYM BioSciences Inc., have become subject to a lien in the United States, pursuant to a court order, to a third party.
An emergency physician-led workgroup has published five primary and seven secondary recommendations about how to maximize the value of health information exchange (HIE) in emergency departments. The recommendations were published online Tuesday in Annals of Emergency Medicine ("Health Information Exchange in Emergency Medicine").
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Biometric systems are no longer reserved for Government users. Enterprise markets such as Banking and Corporations are increasingly seeing the benefits offered by biometric solutions. To accommodate these new opportunities, Precise Biometrics launches a new generation of competitive fingerprint readers which are designed to meet a range of specific but different customer demands.
More and more people are surviving their cancer. Unfortunately, sometimes survival can come with pain. Although many people won't feel any pain after their cancer treatment, some may have chronic, bothersome pain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karla Daniela Calzada Morales, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 789-3000 | Karla Daniela Calzada Morales, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 789-3000 |
News Archive
YM BioSciences Inc., announces that it filed a Form 6K describing that certain US patents for nimotuzumab licensed to YM's majority-owned Canadian subsidiary , CIMYM BioSciences Inc., have become subject to a lien in the United States, pursuant to a court order, to a third party.
An emergency physician-led workgroup has published five primary and seven secondary recommendations about how to maximize the value of health information exchange (HIE) in emergency departments. The recommendations were published online Tuesday in Annals of Emergency Medicine ("Health Information Exchange in Emergency Medicine").
Unigene Laboratories, Inc. today announced that the Company terminated its amended and restated exclusive worldwide license agreement and related development services and clinical supply agreement with GlaxoSmithKline (GSK) pertaining to an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women.
Biometric systems are no longer reserved for Government users. Enterprise markets such as Banking and Corporations are increasingly seeing the benefits offered by biometric solutions. To accommodate these new opportunities, Precise Biometrics launches a new generation of competitive fingerprint readers which are designed to meet a range of specific but different customer demands.
More and more people are surviving their cancer. Unfortunately, sometimes survival can come with pain. Although many people won't feel any pain after their cancer treatment, some may have chronic, bothersome pain.
› Verified 6 days ago
Monika Batra, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Dr. Joseph Michael Cocozzella, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Quinn Building 3rd Floor, Brighton, MA 02135 Phone: 617-789-2117 | |
Thetsu Mon, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-2925 | |
Jared Keith Trout, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Dr. Rania Mohammed Albesher, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Quinn Building, Brighton, MA 02135 Phone: 617-789-3000 | |
Juan R Condemarin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 129 Bigelow St, Brighton, MA 02135 Phone: 617-254-4349 |